During the past decade, National Center for Tumor Diseases conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Center for Tumor Diseases" #1 collaborator was "Charite University, Berlin, Germany" with 1 trials as a collaborator, "University Clinic Cologne" with 1 trials as a collaborator and "University Clinic Essen" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "National Center for Tumor Diseases" are "Cancer" (1 trials), "Early-stage Breast Cancer" (1 trials), "Exercise" (1 trials), "Fatigue" (1 trials) and "Physical Activity" (1 trials). Many other conditions were trialed in "National Center for Tumor Diseases" in a lesser frequency.

Most popular intervention types in "National Center for Tumor Diseases" are "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab 1200 mg in 20 ML Injection" (1 trials), "Exercise - App" (1 trials), "Exercise - Social Media" (1 trials), "Exercise - closed to patients residence" (1 trials) and "Inavolisib" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Center for Tumor Diseases" are 2 trials for "All" genders.

Currently, there are NaN active trials in "National Center for Tumor Diseases". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in National Center for Tumor Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Center for Tumor Diseases, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".